source
- GSK drops Phase 3 chronic cough drug in a blow to $2B Bellus Health buyoutIn a major stumble for GSK’s $2 billion acquisition of Bellus Health, the UK pharma said Friday it is ending development of camlipixant in refractory chronic cough (RCC) after the drug ...Endpoints · 12d ago↗ source
- Zealand Pharma gets its US marketing leader from Lilly; Bexorg turns to Biohaven for CSO hire→ Silvia Luque announced on LinkedIn that she was named head of US marketing at Zealand Pharma after 13 years in various roles at obesity competitor Eli Lilly. She had been ...Endpoints · 12d ago↗ source
- Taylor Fresh Foods Recalls Iceberg Lettuce from Central Mexico Because of Possible Health RiskTaylor Farms de Mexico of Guanajuato, Mexico is voluntarily removing all iceberg lettuce sourced from central Mexico from the U.S. market, because it has the potential to be contaminated with Cyclo…